FDA warns against breast milk drug

Article Abstract:

The Food and Drug Administration (FDA) has warned that the unapproved drug domperidone, being used by many breast-feeding women to increase milk production, may induce arrhythmias, cardiac arrest or even sudden death and they want women to stop consuming this drug. The warning came after reports said that many women were purchasing this drug from pharmacies that prepare it in bulk ingredients or from foreign sources.

Risk factors, Breast milk

---

A perspective on US drug reimportation

Article Abstract:

The US Food and Drug Administration (FDA) opposes the practice of drug reimportation on the grounds that it is unable to ensure the safety of Canadian medications. The reasons why reimportation is a poor policy choice if America's aim is to reduce costs are demonstrated.

General services, Commodity & service prices, Imports, Safety and security measures, Prices and rates, Company pricing policy

---

Similar abstracts:

• Abstracts: What clinicians should know about the QT interval. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies
• Abstracts: Learning from past complaints to improve the care of patients. Are nurse picking up doctors' unwanted tasks?
• Abstracts: Congress OKs drug reimportation from Canada with safety caveat. Congress breathes new life into drug importation law
• Abstracts: Kept practicing, even while a patient. Office physicians more open to hospitalists
• Abstracts: Understanding the experience of training for overseas nurses

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.